0.025485
0.000000
0.000000
0.000000
0.025485
0.000000
0.000000
0.000000
0.008006
0.00000
0.00000
0.00000
Brzozowski, A.M.
Jiracek, J.
Zakova, L.
Antolikova, E.
Watson, C.J.
Turkenburg, J.P.
Dodson, G.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
39.239
39.239
124.908
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C4 H9 N O2
103.120
n
N-methyl-L-alanine
L-peptide linking
Na 1
22.990
SODIUM ION
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
N
1
N
N
N
2
S
C
N
3
N
C
N
4
N
O
N
5
N
C
N
6
N
O
N
7
N
H
N
8
N
H
N
9
N
H
N
10
N
H
N
11
N
H
N
12
N
H
N
13
N
H
N
14
N
N
N
15
S
C
N
16
N
C
N
17
N
O
N
18
N
C
N
19
N
C
N
20
N
C
N
21
N
N
N
22
N
C
N
23
N
N
N
24
N
N
N
25
N
O
N
26
N
H
N
27
N
H
N
28
N
H
N
29
N
H
N
30
N
H
N
31
N
H
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
N
N
42
S
C
N
43
N
C
N
44
N
O
N
45
N
C
N
46
N
C
N
47
N
O
N
48
N
N
N
49
N
O
N
50
N
H
N
51
N
H
N
52
N
H
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
N
N
59
R
C
N
60
N
C
N
61
N
O
N
62
N
C
N
63
N
S
N
64
N
O
N
65
N
H
N
66
N
H
N
67
N
H
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
N
N
73
S
C
N
74
N
C
N
75
N
O
N
76
N
C
N
77
N
C
N
78
N
C
N
79
N
O
N
80
N
N
N
81
N
O
N
82
N
H
N
83
N
H
N
84
N
H
N
85
N
H
N
86
N
H
N
87
N
H
N
88
N
H
N
89
N
H
N
90
N
H
N
91
N
H
N
92
N
N
N
93
S
C
N
94
N
C
N
95
N
O
N
96
N
C
N
97
N
C
N
98
N
C
N
99
N
O
N
100
N
O
N
101
N
O
N
102
N
H
N
103
N
H
N
104
N
H
N
105
N
H
N
106
N
H
N
107
N
H
N
108
N
H
N
109
N
H
N
110
N
H
N
111
N
N
N
112
N
C
N
113
N
C
N
114
N
O
N
115
N
O
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
H
N
120
N
H
N
121
N
N
N
122
S
C
N
123
N
C
N
124
N
O
N
125
N
C
Y
126
N
C
Y
127
N
N
Y
128
N
C
Y
129
N
C
Y
130
N
N
N
131
N
O
N
132
N
H
N
133
N
H
N
134
N
H
N
135
N
H
N
136
N
H
N
137
N
H
N
138
N
H
N
139
N
H
N
140
N
H
N
141
N
H
N
142
N
O
N
143
N
H
N
144
N
H
N
145
N
N
N
146
S
C
N
147
N
C
N
148
N
O
N
149
S
C
N
150
N
C
N
151
N
C
N
152
N
C
N
153
N
O
N
154
N
H
N
155
N
H
N
156
N
H
N
157
N
H
N
158
N
H
N
159
N
H
N
160
N
H
N
161
N
H
N
162
N
H
N
163
N
H
N
164
N
H
N
165
N
H
N
166
N
H
N
167
N
N
N
168
S
C
N
169
N
C
N
170
N
O
N
171
N
C
N
172
N
C
N
173
N
C
N
174
N
C
N
175
N
O
N
176
N
H
N
177
N
H
N
178
N
H
N
179
N
H
N
180
N
H
N
181
N
H
N
182
N
H
N
183
N
H
N
184
N
H
N
185
N
H
N
186
N
H
N
187
N
H
N
188
N
H
N
189
N
N
N
190
S
C
N
191
N
C
N
192
N
O
N
193
N
C
N
194
N
C
N
195
N
C
N
196
N
C
N
197
N
N
N
198
N
O
N
199
N
H
N
200
N
H
N
201
N
H
N
202
N
H
N
203
N
H
N
204
N
H
N
205
N
H
N
206
N
H
N
207
N
H
N
208
N
H
N
209
N
H
N
210
N
H
N
211
N
H
N
212
N
H
N
213
N
H
N
214
N
N
N
215
N
C
N
216
S
C
N
217
N
C
N
218
N
C
N
219
N
O
N
220
N
O
N
221
N
H
N
222
N
H
N
223
N
H
N
224
N
H
N
225
N
H
N
226
N
H
N
227
N
H
N
228
N
H
N
229
N
H
N
230
N
NA
N
231
N
N
N
232
S
C
N
233
N
C
N
234
N
O
N
235
N
C
Y
236
N
C
Y
237
N
C
Y
238
N
C
Y
239
N
C
Y
240
N
C
Y
241
N
C
N
242
N
O
N
243
N
H
N
244
N
H
N
245
N
H
N
246
N
H
N
247
N
H
N
248
N
H
N
249
N
H
N
250
N
H
N
251
N
H
N
252
N
H
N
253
N
H
N
254
N
N
N
255
S
C
N
256
N
C
N
257
N
O
N
258
N
C
N
259
N
C
N
260
N
C
N
261
N
O
N
262
N
H
N
263
N
H
N
264
N
H
N
265
N
H
N
266
N
H
N
267
N
H
N
268
N
H
N
269
N
H
N
270
N
H
N
271
N
N
N
272
S
C
N
273
N
C
N
274
N
O
N
275
N
C
N
276
N
O
N
277
N
O
N
278
N
H
N
279
N
H
N
280
N
H
N
281
N
H
N
282
N
H
N
283
N
H
N
284
N
H
N
285
N
N
N
286
S
C
N
287
N
C
N
288
N
O
N
289
R
C
N
290
N
O
N
291
N
C
N
292
N
O
N
293
N
H
N
294
N
H
N
295
N
H
N
296
N
H
N
297
N
H
N
298
N
H
N
299
N
H
N
300
N
H
N
301
N
H
N
302
N
N
N
303
S
C
N
304
N
C
N
305
N
O
N
306
N
C
Y
307
N
C
Y
308
N
C
Y
309
N
C
Y
310
N
C
Y
311
N
C
Y
312
N
C
N
313
N
O
N
314
N
O
N
315
N
H
N
316
N
H
N
317
N
H
N
318
N
H
N
319
N
H
N
320
N
H
N
321
N
H
N
322
N
H
N
323
N
H
N
324
N
H
N
325
N
H
N
326
N
N
N
327
S
C
N
328
N
C
N
329
N
O
N
330
N
C
N
331
N
C
N
332
N
C
N
333
N
O
N
334
N
H
N
335
N
H
N
336
N
H
N
337
N
H
N
338
N
H
N
339
N
H
N
340
N
H
N
341
N
H
N
342
N
H
N
343
N
H
N
344
N
H
N
1
N
sing
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
doub
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
doub
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
doub
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
doub
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
doub
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
doub
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
doub
N
75
N
sing
N
76
N
sing
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
sing
N
82
N
doub
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
sing
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
doub
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
doub
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
sing
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
doub
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
sing
N
118
N
sing
N
119
N
sing
N
120
N
doub
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
Y
125
N
sing
Y
126
N
doub
Y
127
N
doub
N
128
N
sing
Y
129
N
sing
N
130
N
sing
Y
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
sing
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
doub
N
144
N
sing
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
sing
N
149
N
sing
N
150
N
sing
N
151
N
sing
N
152
N
sing
N
153
N
sing
N
154
N
sing
N
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
doub
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
doub
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
N
193
N
sing
N
194
N
sing
N
195
N
sing
N
196
N
sing
N
197
N
sing
N
198
N
sing
N
199
N
sing
N
200
N
sing
N
201
N
sing
N
202
N
sing
N
203
N
sing
N
204
N
sing
N
205
N
sing
N
206
N
sing
N
207
N
sing
N
208
N
sing
N
209
N
sing
N
210
N
sing
N
211
N
sing
N
212
N
sing
N
213
N
sing
N
214
N
sing
N
215
N
doub
N
216
N
sing
N
217
N
sing
N
218
N
sing
N
219
N
sing
N
220
N
sing
N
221
N
sing
N
222
N
sing
N
223
N
sing
N
224
N
doub
N
225
N
sing
N
226
N
sing
N
227
N
sing
N
228
N
sing
Y
229
N
doub
Y
230
N
sing
Y
231
N
sing
N
232
N
sing
Y
233
N
doub
N
234
N
sing
Y
235
N
doub
N
236
N
sing
Y
237
N
sing
N
238
N
sing
N
239
N
sing
N
240
N
sing
N
241
N
sing
N
242
N
sing
N
243
N
sing
N
244
N
sing
N
245
N
sing
N
246
N
sing
N
247
N
doub
N
248
N
sing
N
249
N
sing
N
250
N
sing
N
251
N
sing
N
252
N
sing
N
253
N
sing
N
254
N
sing
N
255
N
sing
N
256
N
sing
N
257
N
sing
N
258
N
sing
N
259
N
sing
N
260
N
sing
N
261
N
sing
N
262
N
sing
N
263
N
sing
N
264
N
doub
N
265
N
sing
N
266
N
sing
N
267
N
sing
N
268
N
sing
N
269
N
sing
N
270
N
sing
N
271
N
sing
N
272
N
sing
N
273
N
sing
N
274
N
sing
N
275
N
sing
N
276
N
sing
N
277
N
doub
N
278
N
sing
N
279
N
sing
N
280
N
sing
N
281
N
sing
N
282
N
sing
N
283
N
sing
N
284
N
sing
N
285
N
sing
N
286
N
sing
N
287
N
sing
N
288
N
sing
N
289
N
sing
N
290
N
sing
N
291
N
sing
N
292
N
sing
N
293
N
doub
N
294
N
sing
N
295
N
sing
N
296
N
sing
N
297
N
sing
Y
298
N
doub
Y
299
N
sing
Y
300
N
sing
N
301
N
sing
Y
302
N
doub
N
303
N
sing
Y
304
N
doub
N
305
N
sing
Y
306
N
sing
N
307
N
sing
N
308
N
sing
N
309
N
sing
N
310
N
sing
N
311
N
sing
N
312
N
sing
N
313
N
sing
N
314
N
sing
N
315
N
sing
N
316
N
sing
N
317
N
doub
N
318
N
sing
N
319
N
sing
N
320
N
sing
N
321
N
sing
N
322
N
sing
N
323
N
sing
N
324
N
sing
N
325
N
sing
N
326
N
sing
N
327
N
sing
N
328
N
sing
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
107
1966
10.1073/PNAS.0911785107
20133841
Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues.
2010
10.2210/pdb2wrx/pdb
pdb_00002wrx
ARG B 22 C-ALPHA IS PLANAR
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2008-01-30
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
1.07230
1.0
ID14-1
ESRF
1.07230
SYNCHROTRON
ESRF BEAMLINE ID14-1
2383.698
INSULIN A CHAIN
2
syn
polymer
METHYLATION OF B26 AND D26 PEPTIDE NITROGEN ATOM IN B AND D CHAIN OF HUMAN INSULIN
3355.884
INSULIN B CHAIN
YES
2
syn
polymer
22.990
SODIUM ION
1
syn
non-polymer
18.015
water
101
nat
water
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A,C
polypeptide(L)
no
yes
FVNQHLCGSHLVEALYLVCGERGFF(MAA)TPKT
FVNQHLCGSHLVEALYLVCGERGFFATPKT
B,D
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
2.4
48
NONE
3.0
0.18 M LI2SO4, 0.1M NA ACETATE PH 3.0
chem_comp_atom
chem_comp_bond
database_2
pdbx_database_status
pdbx_initial_refinement_model
pdbx_struct_conn_angle
struct_conn
struct_site
repository
Initial release
Advisory
Atomic model
Database references
Derived calculations
Non-polymer description
Other
Version format compliance
Data collection
Database references
Derived calculations
Other
Refinement description
1
0
2010-02-09
1
1
2012-04-04
1
2
2023-12-20
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_sf
_pdbx_struct_conn_angle.ptnr1_auth_asym_id
_pdbx_struct_conn_angle.ptnr1_auth_seq_id
_pdbx_struct_conn_angle.ptnr1_label_asym_id
_pdbx_struct_conn_angle.ptnr3_auth_asym_id
_pdbx_struct_conn_angle.ptnr3_auth_seq_id
_pdbx_struct_conn_angle.ptnr3_label_asym_id
_pdbx_struct_conn_angle.value
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr2_auth_asym_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES)
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10- ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE
INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES
STRUCTURE OF INSULIN
CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN
T6 HUMAN INSULIN AT 1.0 A RESOLUTION
CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)
DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2)
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)];
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES
INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS
THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER
STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER
ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES
DEHYDRATED T6 HUMAN INSULIN AT 295 K
INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION.
R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES
SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28) ->THR] INSULIN MUTANT (PT INSULIN)
NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY
STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
DEHYDRATED T6 HUMAN INSULIN AT 100 K
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER
CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS- B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10- ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE
CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY.
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10- ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D;
CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN
NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC- FREE, 10 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS- B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A- CHAINVARIANT INSULIN WAKAYAMA
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE
1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
INSULIN, MONOCLINIC CRYSTAL FORM
STRUCTURE OF INSULIN
INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES)
HUMAN INSULIN MUTANT SERB9GLU
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE
STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT.
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES)
LYS(B28)PRO(B29)-HUMAN INSULIN
AN ACTIVE MINI-PROINSULIN, M2PI
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES
INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3- GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D- PROB26-DTI-NH2
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI-NH2
PDBE
Y
PDBE
2009-09-02
REL
REL
NA
SODIUM ION
HOH
water
9606
HUMAN
HOMO SAPIENS
sample
9606
HUMAN
HOMO SAPIENS
sample
ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO MAA
ENGINEERED RESIDUE IN CHAIN D, TYR 50 TO MAA
SODIUM (NA): SODIUM CATION
26 TYR MUTATED TO ALA AND N ATOM OF B26 PEPTIDE IS
METHYLATED
26 TYR MUTATED TO ALA AND N ATOM OF D26 PEPTIDE IS
METHYLATED
1MSO
PDB ENTRY 1MSO
PDB
experimental model
NA
2000
3
NA
NA
2000
A
HOH
2001
4
HOH
HOH
2001
A
HOH
2002
4
HOH
HOH
2002
A
HOH
2003
4
HOH
HOH
2003
A
HOH
2004
4
HOH
HOH
2004
A
HOH
2005
4
HOH
HOH
2005
A
HOH
2006
4
HOH
HOH
2006
A
HOH
2007
4
HOH
HOH
2007
A
HOH
2008
4
HOH
HOH
2008
A
HOH
2009
4
HOH
HOH
2009
A
HOH
2010
4
HOH
HOH
2010
A
HOH
2011
4
HOH
HOH
2011
A
HOH
2012
4
HOH
HOH
2012
A
HOH
2013
4
HOH
HOH
2013
A
HOH
2014
4
HOH
HOH
2014
A
HOH
2015
4
HOH
HOH
2015
A
HOH
2016
4
HOH
HOH
2016
A
HOH
2017
4
HOH
HOH
2017
A
HOH
2018
4
HOH
HOH
2018
A
HOH
2019
4
HOH
HOH
2019
A
HOH
2020
4
HOH
HOH
2020
A
HOH
2021
4
HOH
HOH
2021
A
HOH
2022
4
HOH
HOH
2022
A
HOH
2023
4
HOH
HOH
2023
A
HOH
2024
4
HOH
HOH
2024
A
HOH
2025
4
HOH
HOH
2025
A
HOH
2001
4
HOH
HOH
2001
B
HOH
2002
4
HOH
HOH
2002
B
HOH
2003
4
HOH
HOH
2003
B
HOH
2004
4
HOH
HOH
2004
B
HOH
2005
4
HOH
HOH
2005
B
HOH
2006
4
HOH
HOH
2006
B
HOH
2007
4
HOH
HOH
2007
B
HOH
2008
4
HOH
HOH
2008
B
HOH
2009
4
HOH
HOH
2009
B
HOH
2010
4
HOH
HOH
2010
B
HOH
2011
4
HOH
HOH
2011
B
HOH
2012
4
HOH
HOH
2012
B
HOH
2013
4
HOH
HOH
2013
B
HOH
2014
4
HOH
HOH
2014
B
HOH
2015
4
HOH
HOH
2015
B
HOH
2016
4
HOH
HOH
2016
B
HOH
2017
4
HOH
HOH
2017
B
HOH
2018
4
HOH
HOH
2018
B
HOH
2019
4
HOH
HOH
2019
B
HOH
2020
4
HOH
HOH
2020
B
HOH
2021
4
HOH
HOH
2021
B
HOH
2022
4
HOH
HOH
2022
B
HOH
2001
4
HOH
HOH
2001
C
HOH
2002
4
HOH
HOH
2002
C
HOH
2003
4
HOH
HOH
2003
C
HOH
2004
4
HOH
HOH
2004
C
HOH
2005
4
HOH
HOH
2005
C
HOH
2006
4
HOH
HOH
2006
C
HOH
2007
4
HOH
HOH
2007
C
HOH
2008
4
HOH
HOH
2008
C
HOH
2009
4
HOH
HOH
2009
C
HOH
2010
4
HOH
HOH
2010
C
HOH
2011
4
HOH
HOH
2011
C
HOH
2012
4
HOH
HOH
2012
C
HOH
2013
4
HOH
HOH
2013
C
HOH
2014
4
HOH
HOH
2014
C
HOH
2015
4
HOH
HOH
2015
C
HOH
2016
4
HOH
HOH
2016
C
HOH
2017
4
HOH
HOH
2017
C
HOH
2018
4
HOH
HOH
2018
C
HOH
2019
4
HOH
HOH
2019
C
HOH
2020
4
HOH
HOH
2020
C
HOH
2021
4
HOH
HOH
2021
C
HOH
2022
4
HOH
HOH
2022
C
HOH
2023
4
HOH
HOH
2023
C
HOH
2024
4
HOH
HOH
2024
C
HOH
2001
4
HOH
HOH
2001
D
HOH
2002
4
HOH
HOH
2002
D
HOH
2003
4
HOH
HOH
2003
D
HOH
2004
4
HOH
HOH
2004
D
HOH
2005
4
HOH
HOH
2005
D
HOH
2006
4
HOH
HOH
2006
D
HOH
2007
4
HOH
HOH
2007
D
HOH
2008
4
HOH
HOH
2008
D
HOH
2009
4
HOH
HOH
2009
D
HOH
2010
4
HOH
HOH
2010
D
HOH
2011
4
HOH
HOH
2011
D
HOH
2012
4
HOH
HOH
2012
D
HOH
2013
4
HOH
HOH
2013
D
HOH
2014
4
HOH
HOH
2014
D
HOH
2015
4
HOH
HOH
2015
D
HOH
2016
4
HOH
HOH
2016
D
HOH
2017
4
HOH
HOH
2017
D
HOH
2018
4
HOH
HOH
2018
D
HOH
2019
4
HOH
HOH
2019
D
HOH
2020
4
HOH
HOH
2020
D
HOH
2021
4
HOH
HOH
2021
D
HOH
2022
4
HOH
HOH
2022
D
HOH
2023
4
HOH
HOH
2023
D
HOH
2024
4
HOH
HOH
2024
D
HOH
2025
4
HOH
HOH
2025
D
HOH
2026
4
HOH
HOH
2026
D
HOH
2027
4
HOH
HOH
2027
D
HOH
2028
4
HOH
HOH
2028
D
HOH
2029
4
HOH
HOH
2029
D
HOH
2030
4
HOH
HOH
2030
D
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
n
1
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
MAA
26
n
26
MAA
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
n
29
29
B
n
30
30
B
GLY
1
n
1
GLY
1
C
ILE
2
n
2
ILE
2
C
VAL
3
n
3
VAL
3
C
GLU
4
n
4
GLU
4
C
GLN
5
n
5
GLN
5
C
CYS
6
n
6
CYS
6
C
CYS
7
n
7
CYS
7
C
THR
8
n
8
THR
8
C
SER
9
n
9
SER
9
C
ILE
10
n
10
ILE
10
C
CYS
11
n
11
CYS
11
C
SER
12
n
12
SER
12
C
LEU
13
n
13
LEU
13
C
TYR
14
n
14
TYR
14
C
GLN
15
n
15
GLN
15
C
LEU
16
n
16
LEU
16
C
GLU
17
n
17
GLU
17
C
ASN
18
n
18
ASN
18
C
TYR
19
n
19
TYR
19
C
CYS
20
n
20
CYS
20
C
ASN
21
n
21
ASN
21
C
n
1
1
D
VAL
2
n
2
VAL
2
D
ASN
3
n
3
ASN
3
D
GLN
4
n
4
GLN
4
D
HIS
5
n
5
HIS
5
D
LEU
6
n
6
LEU
6
D
CYS
7
n
7
CYS
7
D
GLY
8
n
8
GLY
8
D
SER
9
n
9
SER
9
D
HIS
10
n
10
HIS
10
D
LEU
11
n
11
LEU
11
D
VAL
12
n
12
VAL
12
D
GLU
13
n
13
GLU
13
D
ALA
14
n
14
ALA
14
D
LEU
15
n
15
LEU
15
D
TYR
16
n
16
TYR
16
D
LEU
17
n
17
LEU
17
D
VAL
18
n
18
VAL
18
D
CYS
19
n
19
CYS
19
D
GLY
20
n
20
GLY
20
D
GLU
21
n
21
GLU
21
D
ARG
22
n
22
ARG
22
D
GLY
23
n
23
GLY
23
D
PHE
24
n
24
PHE
24
D
PHE
25
n
25
PHE
25
D
MAA
26
n
26
MAA
26
D
THR
27
n
27
THR
27
D
PRO
28
n
28
PRO
28
D
n
29
29
D
n
30
30
D
0.8900
-1.0387
0.3188
5.8128
-1.4872
3.1336
-0.2104
-0.0773
0.0381
0.2535
0.3001
0.1191
-0.0732
-0.3912
-0.0897
0.0671
0.0413
-0.0136
0.0871
-0.0040
0.0272
refined
2.9776
17.9637
24.4580
X-RAY DIFFRACTION
1.6061
-0.0111
0.1928
3.2814
-2.2017
5.0776
-0.0731
-0.1265
0.0015
-0.2569
0.1590
0.1646
0.3006
-0.5990
-0.0859
0.0922
-0.0700
-0.0022
0.1154
-0.0083
0.0272
refined
1.9202
19.7296
8.1554
X-RAY DIFFRACTION
A
1
A
21
X-RAY DIFFRACTION
1
B
2
B
29
X-RAY DIFFRACTION
1
C
1
C
21
X-RAY DIFFRACTION
2
D
2
D
28
X-RAY DIFFRACTION
2
author_and_software_defined_assembly
PISA
4
tetrameric
3490
-46.3
6120
A
HOH
2001
F
O
HOH
1_555
A
NA
2000
E
NA
NA
1_555
B
HOH
2019
G
O
HOH
1_555
138.8
A
HOH
2001
F
O
HOH
1_555
A
NA
2000
E
NA
NA
1_555
D
HOH
2026
I
O
HOH
1_555
77.0
B
HOH
2019
G
O
HOH
1_555
A
NA
2000
E
NA
NA
1_555
D
HOH
2026
I
O
HOH
1_555
117.5
B
MAA
26
N-METHYL-L-ALANINE
B
MAA
26
ALA
D
MAA
26
N-METHYL-L-ALANINE
D
MAA
26
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
CG
GLU
21
B
CG
GLU
21
0
Y
1
B
CD
GLU
21
B
CD
GLU
21
0
Y
1
B
OE1
GLU
21
B
OE1
GLU
21
0
Y
1
B
OE2
GLU
21
B
OE2
GLU
21
0
Y
1
B
CB
ARG
22
B
CB
ARG
22
0
Y
1
B
CG
ARG
22
B
CG
ARG
22
0
Y
1
B
CD
ARG
22
B
CD
ARG
22
0
Y
1
B
NE
ARG
22
B
NE
ARG
22
0
Y
1
B
CZ
ARG
22
B
CZ
ARG
22
0
Y
1
B
NH1
ARG
22
B
NH1
ARG
22
0
Y
1
B
NH2
ARG
22
B
NH2
ARG
22
0
Y
1
D
CG
GLU
21
D
CG
GLU
21
0
Y
1
D
CD
GLU
21
D
CD
GLU
21
0
Y
1
D
OE1
GLU
21
D
OE1
GLU
21
0
Y
1
D
OE2
GLU
21
D
OE2
GLU
21
0
Y
1
B
PHE
1
B
PHE
1
1
Y
1
B
LYS
29
B
LYS
29
1
Y
1
B
THR
30
B
THR
30
1
Y
1
D
PHE
1
D
PHE
1
1
Y
1
D
LYS
29
D
LYS
29
1
Y
1
D
THR
30
D
THR
30
1
Y
1
B
CA
ARG
22
PLANAR
1
B
B
GLU
ARG
21
22
73.93
1
17.30
2.70
111.00
128.30
B
B
B
N
CA
C
GLU
GLU
GLU
21
21
21
N
1
32.07
2.00
110.40
142.47
B
B
B
CB
CA
C
ARG
ARG
ARG
22
22
22
N
1
17.70
2.20
113.40
131.10
B
B
B
CA
CB
CG
ARG
ARG
ARG
22
22
22
N
1
B
B
CA
CB
ARG
ARG
22
22
-0.440
0.022
1.535
1.095
N
1
D
D
CB
CG
GLU
GLU
13
13
0.115
0.019
1.517
1.632
N
1
D
D
CB
CG
GLU
GLU
21
21
-0.183
0.019
1.517
1.334
N
1
A
C
O
O
HOH
HOH
2019
2005
0.00
1_555
5_555
1
A
C
OE1
OE2
GLU
GLU
4
4
1.72
1_555
5_555
1
B
ARG
22
68.41
-110.83
1
B
MAA
26
-117.21
53.30
1
C
CYS
7
-96.14
-61.00
17.567
0.78
0.00
0.00
0.78
0.00
-1.55
0.966
0.948
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES RESIDUAL ONLY. B1 PHE IS NOT MODELLED. B29 LYS AND B30 THR ARE NOT MODELLED. B21 GLU SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. B22 ARG SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. D1 PHE IS NOT MODELLED. D29 LYS AND D30 THR ARE NOT MODELLED. D21 GLU SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. D22 ARG SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO.
0.25053
0.18019
0.18343
1.50
37.42
787
14801
5.0
94.63
4.273
0.069
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.096
0.093
0.80
0.80
1.20
PDB ENTRY 1MSO
MAXIMUM LIKELIHOOD
MASK
1.50
37.42
101
844
1
0
742
0.023
0.022
767
1.980
1.954
1051
9.222
5.000
100
32.862
25.294
34
11.362
15.000
114
21.593
15.000
1
0.146
0.200
122
0.010
0.020
581
1.980
1.500
485
2.826
2.000
777
3.877
3.000
282
5.540
4.500
270
2.291
3.000
767
8.454
3.000
102
5.535
3.000
745
0.312
0.283
1.539
33
649
20
57.70
20.2
1.50
30.00
2WRX
17552
0.0
0.06
1
9.20
13.4
94.6
0.47
1.50
1.55
5.50
1
1.5
60.5
refinement
REFMAC
5.5.0082
data reduction
DENZO
data scaling
SCALEPACK
phasing
MOLREP
Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0
1
N
N
2
N
N
1
N
N
2
N
N
3
N
N
4
N
N
4
N
N
4
N
N
4
N
N
A
ILE
2
A
ILE
2
HELX_P
A
CYS
7
A
CYS
7
1
1
6
A
SER
12
A
SER
12
HELX_P
A
ASN
18
A
ASN
18
1
2
7
B
SER
9
B
SER
9
HELX_P
B
CYS
19
B
CYS
19
1
3
11
C
ILE
2
C
ILE
2
HELX_P
C
CYS
7
C
CYS
7
1
4
6
C
SER
12
C
SER
12
HELX_P
C
ASN
18
C
ASN
18
1
5
7
D
SER
9
D
SER
9
HELX_P
D
CYS
19
D
CYS
19
1
6
11
disulf
2.049
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.091
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.016
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
disulf
2.081
C
CYS
6
C
SG
CYS
6
1_555
C
CYS
11
C
SG
CYS
11
1_555
disulf
2.060
C
CYS
7
C
SG
CYS
7
1_555
D
CYS
7
D
SG
CYS
7
1_555
disulf
2.017
C
CYS
20
C
SG
CYS
20
1_555
D
CYS
19
D
SG
CYS
19
1_555
covale
1.337
both
B
PHE
25
B
C
PHE
25
1_555
B
MAA
26
B
N
MAA
26
1_555
covale
1.321
both
B
MAA
26
B
C
MAA
26
1_555
B
THR
27
B
N
THR
27
1_555
covale
1.345
both
D
PHE
25
D
C
PHE
25
1_555
D
MAA
26
D
N
MAA
26
1_555
covale
1.329
both
D
MAA
26
D
C
MAA
26
1_555
D
THR
27
D
N
THR
27
1_555
metalc
3.144
A
NA
2000
E
NA
NA
1_555
A
HOH
2001
F
O
HOH
1_555
metalc
3.058
A
NA
2000
E
NA
NA
1_555
B
HOH
2019
G
O
HOH
1_555
metalc
2.620
A
NA
2000
E
NA
NA
1_555
D
HOH
2026
I
O
HOH
1_555
HORMONE
CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, DIABETES MELLITUS
B
PHE
25
B
PHE
25
1
B
MAA
26
B
MAA
26
4.55
D
PHE
25
D
PHE
25
1
D
MAA
26
D
MAA
26
12.89
INS_HUMAN
UNP
1
P01308
INS_HUMAN
UNP
2
P01308
90
110
2WRX
1
21
P01308
A
1
1
21
25
54
2WRX
1
30
P01308
B
2
1
30
90
110
2WRX
1
21
P01308
C
1
1
21
25
54
2WRX
1
30
P01308
D
2
1
30
2
TYR
engineered mutation
MAA
26
2WRX
B
P01308
UNP
50
26
4
TYR
engineered mutation
MAA
26
2WRX
D
P01308
UNP
50
26
BINDING SITE FOR RESIDUE NA A 2000
A
NA
2000
Software
2
B
HOH
2019
G
HOH
2
1_555
D
HOH
2026
I
HOH
2
1_555
92
P 41 21 2